🎉 M&A multiples are live!
Check it out!

Public Comps and Valuation Multiples
for Pharma Diagnostics & Analytics

Benchmark revenue and EBITDA valuation multiples for public comps like Wantai BioPharm, Sepax Technologies, Bioventix, Biohit and Genomictree.

Pharma Diagnostics & Analytics

See analyst estimates and all valuation multiples for Pharma Diagnostics & Analytics
Company EV EV/Revenue EV/EBITDA
$10.8B 26.4x 80.7x
$8.2B 6.8x 19.5x
$1.3B 6.5x -19.1x
$1.3B 4.8x -8.6x
$896M 19.4x n/a
$191M 10.6x 13.9x
$181M n/a n/a
$155M 6.8x -5.0x
$38.4M 2.2x 11.8x
$29.9M 12.4x -7.5x
$19.0M n/a -7.9x
$10.6M n/a n/a
-$17.1M -0.6x n/a
-$21.2M n/a 0.3x

Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.

See analyst estimates and M&A multiples for Pharma Diagnostics & Analytics

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.